Enzyme Therapy for Lyme Disease Support: Breaking Down Biofilms

One of the greatest challenges in addressing chronic Lyme disease is the ability of Borrelia burgdorferi and associated co-infections to form biofilms. Biofilms are protective structures made of proteins, sugars, and fibrin that bacteria create to shield themselves from the immune system and conventional treatments.

These protective layers allow microbes to hide, persist, and resist eradication, which is why many practitioners explore strategies aimed at disrupting these biofilms.

One area of growing interest in integrative Lyme support is the use of systemic enzymes, which may help break down components of these microbial defenses.

Lumbrokinase

Among the enzymes used in Lyme protocols, lumbrokinase is often considered one of the most powerful fibrinolytic enzymes available.

Derived from earthworms (Lumbricus rubellus), lumbrokinase specifically targets fibrin, a protein that bacteria like Borrelia can use as a structural framework within biofilms. By breaking down fibrin, lumbrokinase may help disrupt these protective structures and expose hidden microbes to the immune system.

Because of this ability to dissolve fibrin-based barriers, lumbrokinase is frequently used in integrative protocols aimed at addressing persistent infections and circulatory stagnation.

Lumbricus Rubellus: Total Extract

While most supplements isolate purified lumbrokinase, the total extract of Lumbricus rubellus contains a natural blend of multiple enzyme fractions, sometimes described as a cocktail of six fibrinolytic enzymes.

In addition to supporting fibrin breakdown, some research suggests compounds within the total extract may support vascular and endothelial health. This may help support tissue recovery and circulation following inflammatory or infectious stress.

Because of this broader activity, some practitioners believe the whole extract provides a more comprehensive enzymatic profile than purified isolates alone.

Serrapeptase

Serrapeptase is another well-known systemic enzyme that has been widely studied for its ability to break down non-living tissue and protein debris in the body.

This enzyme may help digest the protein components of biofilms and reduce excess inflammatory proteins that accumulate during chronic infections. As a result, serrapeptase is often used to support circulation, tissue recovery, and inflammation balance.

It is also sometimes included in protocols to help reduce the inflammatory symptoms that can occur during microbial die-off reactions.

Serratia E-15

While many supplements simply list serrapeptase, Serratia E-15 refers to the original highly purified enzyme strain used in early Japanese clinical research.

This version is known for its high stability and enzymatic activity, and it was historically studied for conditions involving chronic inflammation, sinus congestion, and circulatory disorders.

Because of its potency in breaking down excess protein debris, it is sometimes discussed in integrative medicine circles as a more refined and effective form of serrapeptase.

Nattokinase

Nattokinase, an enzyme derived from the traditional fermented food natto, is primarily known for its role in supporting cardiovascular health.

However, nattokinase is also a fibrinolytic enzyme, meaning it helps break down fibrin. This property may help reduce the fibrin networks that certain pathogens use as hiding places within tissues.

For this reason, nattokinase is sometimes included in Lyme support protocols to help address circulatory stagnation and fibrin accumulation associated with chronic infections.

Dispersin B

One of the most interesting enzymes currently being explored in research is Dispersin B.

Unlike many enzymes that target proteins, Dispersin B works by breaking down polysaccharide biofilm structures, specifically a compound called PNAG (poly-N-acetylglucosamine). This sugar-based material forms part of the protective shield used by many persistent bacteria.

Although still uncommon in consumer supplements, laboratory research has demonstrated that Dispersin B can effectively dismantle certain biofilm matrices, making bacteria more vulnerable to immune defenses and antimicrobial therapies.

A Multi-Targeted Approach

Biofilms are complex structures made up of proteins, fibrin, sugars, and microbial debris, which is why many integrative approaches involve a combination of enzymes rather than relying on a single compound.

By targeting different components of these protective layers, systemic enzymes may help support the body’s ability to break down microbial hiding places, improve circulation, and promote immune recognition of pathogens.

While enzyme therapy is not a standalone cure, it is increasingly being explored as a supportive strategy within comprehensive Lyme protocols that may also include antimicrobial therapies, immune support, and nutritional strategies.

Sources:

1. Sapi, E., Bastian, S. L., Mpoy, C. M., et al. (2012). Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS ONE, 7(10), e48277.

2. Flemming, H.-C., Wingender, J., Szewzyk, U., et al. (2016). Biofilms: An emergent form of bacterial life. Nature Reviews Microbiology, 14(9), 563–575.

3. Bergamini, S., Rota, C., et al. (2012). Effects of serratiopeptidase on inflammation and tissue permeability. Journal of Biological Regulators and Homeostatic Agents, 26(3), 351–360.

4. Fujita, M., Hong, K., Ito, Y., et al. (1993). Thrombolytic effect of nattokinase on a chemically induced thrombosis model. Biological & Pharmaceutical Bulletin, 16(6), 545–548.

5. Jin, L., Jin, H., Zhang, G., Xu, G. (2013). Changes in coagulation and fibrinolysis in patients with chronic Lyme disease. Medical Hypotheses, 81(6), 1036–1038.

6. Zhang, Y., Persson, C., et al. (2011). Dispersin B and its potential role in biofilm disruption. Journal of Antimicrobial Chemotherapy, 66(9), 1963–1971.

7. Miyata, K., Maejima, K., Tomoda, K., Isono, M. (1970). Serratia protease (serrapeptase) as an anti-inflammatory agent. Japanese Pharmacology & Therapeutics.